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Abstract
Background: G-CSF is known to function as a hematopoietic growth factor and it is known to be
responsible for leukocytosis. G-CSF-producing tumors associated with leukocytosis include various
types of malignancies.
Case presentation: We report the case of a 72-year-old man with dedifferentiated
chondrosarcoma characterized by dedifferentiated components of malignant fibrous histiocytoma-
or osteosarcoma-like features in addition to conventional chondrosarcoma, arising from his pelvic
bone. After hemipelvectomy, when local recurrence and metastasis were identified, leukocytosis
appeared and an elevated level of serum granulocyte-colony-stimulating factor (G-CSF) was also
recognized. The patient died of multiple organ failure 2 months after surgery. Autopsy specimens
showed that the histological specimens of the recurrence and metastasis were dedifferentiated
components, without any conventional chondrosarcoma components. G-CSF was expressed only
in the dedifferentiated components, not in the chondrosarcoma components,
immunohistochemically.
Conclusion: This is the first report of chondrosarcoma, or any other primary bone tumor, with
leukocytosis, probably stimulated by tumor-produced G-CSF from the dedifferentiated
components.
Background
Granulocyte-colony stimulating factor (G-CSF) enhances
differentiation along the neutrophil lineage, and acceler-
ates maturation of metamyelocytes into mature neu-
trophils. G-CSF also prolongs the survival of neutrophils
and their precursors, including stem cells[1]. Conse-
quently, G-CSF is known to function as a hematopoietic
growth factor and it is known to be responsible for leuko-
cytosis. Normally, the serum G-CSF level is very low [2].
Production of granulocyte colony-stimulating factor (G-
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CSF) by tumor cells was first identified in lung carcinoma
in 1977 [3]. G-CSF-producing tumors associated with leu-
kocytosis include various types of malignancies, including
lung caner [4,5], colon cancer [4], stomach cancer [4], thy-
roid caner [6], cervical cancer [7], malignant fibrous histi-
ocytoma of soft tissue [8].
Dedifferentiated chondrosarcoma accounts for approxi-
mately 10% of all chondrosarcomas [9]. Dedifferentiated
chondrosarcoma shows both a rapid growth rate and met-
astatic spread, and it has a significantly worse survival rate
compared with conventional chondrosarcoma [10,11].
Dedifferentiated chondrosarcoma shows both a rapid
growth rate and metastatic spread, and it has a signifi-
cantly worse survival rate compared with conventional
chondrosarcoma. The overall 5-year survival rate in con-
ventional chondrosarcoma patients varies between 48%-
60%, on the other hand, dedifferentiated chondrosar-
coma is highly lethal, with less than a 10% survival rate
after 1 year, with practically no long-term survivors [9].
Dedifferentiated chondrosarcoma is characterized by the
coexistence of conventional chondrosarcoma and dedif-
ferentiated components. The dedifferentiated compo-
nents can features of malignant fibrous histiocytoma
(MFH), osteosarcoma, angiosarcoma, fibrosarcoma,
rhabdomyosarcoma, leiomyosarcoma and giant cell
tumor [11]. We report a case of dedifferentiated chondro-
sarcoma with leukocytosis, probably due to stimulation
by tumor-produced G-CSF. This chondrosarcoma with
leukocytosis and an elevated serum G-CSF level is the first
such report not only of chondrosarcoma, but also of any
such primary bone tumor with leukocytosis.
Case presentation
A 72-year-old man, who had been suffering from right hip
pain for 7 years when walking, was referred to our insti-
tute. Roentogenography of the right pelvic bone showed
an expansion of the cortical contour and a soft-tissue mass
with punctate calcification (figure 1). Magnetic resonance
imaging (MRI) showed a lobulated lesion expanding over
the entire right pelvic bone with low-intensity on T1-
weighted imaging and iso- to high-intensity on T2-
weighted imaging, with the tumor protuberant to the pel-
vic cavity (figure 1). Right hemipelvectomy was carried
out. Histological sections showed a conventional chond-
rosarcoma having atypical chondrocytes with hyaline car-
tilage matrix or myxoid matrix (figure 2). In a small
section, dedifferentiated components were also identified,
and these dedifferentiated components consisted of atyp-
ical spindle cells arranged in short fascicles or a storiform
pattern showing MFH-like features, plus some pleomor-
phic cells with lace-like osteoid formation showing oste-
osarcoma-like features (figure 3). Therefore, the final
diagnosis was dedifferentiated chondrosarcoma because
of the coexistence of conventional chondrosarcoma and
dedifferentiated components.
Preoperative laboratory data were not remarkable. After
surgery, the laboratory data also showed leukocytosis pre-
dominantly in the neutrophils with an elevated level of C-
reactive protein (figure 4). The serum level of G-CSF was
also elevated (330 pg/ml [normal, <8 pg/ml]). Magnetic
resonance imaging (MRI) and computed tomography
(CT) revealed evidence of local recurrence and metastatic
lesions in the lungs. Flow-cytometry indicated no evi-
dence of leukemia and serological studies showed no evi-
dence of specific infections, such as candidiasis or
tuberculosis. Despite the administration of several antibi-
otics, the leukocytosis did not disappear. Two months
after the surgery, the patient died of multiple organ fail-
ure. An autopsy was carried out, and in addition to the
lung metastasis, metastasis was also found in the liver,
thyroid, diaphragm, adrenal gland, digestive tract and
skin. The histology of the recurrent and metastatic lesions
was not conventional chondrosarcoma but only dediffer-
entiated components. Immunoexpression of G-CSF (anti-
G-CSF [Ab1], Calbiochem, San Diego CA, USA) was seen
in the dedifferentiated components, but not in the con-
ventional chondrosarcoma components (figure 5).
Discussion
In the current report, we present a case of dedifferentiated
chondrosarcoma with leukocytosis and an increased
serum G-CSF level. In a previous report, serum G-CSF was
not found to be increased in bone tumors, including oste-
osarcoma, chondrosarcoma, Ewing/PNET and giant cell
tumor, compared to the control [12]. Therefore, an eleva-
tion of serum G-CSF seemed to be a specific finding in the
current case. Leukocytosis in the current case was proba-
bly stimulated by tumor-produced G-CSF. G-CSF-produc-
ing tumors associated with leukocytosis are a well-known
phenomenon. Besides tumor cells themselves, neoplastic
necrosis produces multiple cytokines, including G-CSF,
and causes leukecytosis [15]. However, there is less
necrotic area in this dedifferentiated chondrosarcoma.
Moreover, the degree of leukocytosis associated with sur-
gery, such as reactive local inflammation and healing
wound, is mild, which is different from leukocytosis
caused by tumor-produced G-CSF. Taken together, the
leukocytosis seemed to be strongly associated with an ele-
vated serum G-CSF of neoplastic origin. Secondary non-
epithelial tumors with leukocytosis have been reported,
among which there was a case of undifferentiated sarcoma
following a fracture [13] and a case of angiosarcoma fol-
lowing burns [14]. Among the primary bone and soft-tis-
sue tumors, only 5 cases of soft-tissue tumor have been
reported, among which there was one case of MFH [8] and
4 cases of liposarcoma [15-18]. However, to our knowl-World Journal of Surgical Oncology 2006, 4:37 http://www.wjso.com/content/4/1/37
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edge, no bone tumor with leukocytosis plus an elevated
serum G-CSF level has been reported.
In the current case, leukocytosis appeared after the sur-
gery, when recurrence and metastasis also appeared. The
histology of the recurrent and metastatic lesions was not
conventional chondrosarcoma but only dedifferentiated
components. Therefore, it would seem that the G-CSF
production could have been associated with the dediffer-
entiated components. Supporting this idea, G-CSF expres-
sion was found only in the dedifferentiated components,
and not in the conventional chondrosarcoma compo-
nents, immunohistochemically. As described, the histol-
ogy of G-CSF-producing soft-tissue tumors was MFH and
liposarcoma [8,15-18]. The subtype of these reported
liposarcoma cases was pleomorphic type [15,16] and ded-
ifferentiated type [17,18], in 2 cases each. G-CSF produc-
tion in bone and soft-tissue tumors may be related with
undifferentiated sarcoma, such as MFH or sarcomas of
pleomorphic type or dedifferentiated type.
The current case of dedifferentiated chondrosarcoma had
a rather long history of 7 years without leukocytosis prior
to the initial surgery. The resected specimens had conven-
tional chondrosarcoma components in most part, and
dedifferentiated components only in a small part. It is not
clear why there was no leukocytosis before the surgery,
even though there were dedifferentiated components.
One theory is that the volume of dedifferentiated compo-
nents with G-CSF production was too small to cause leu-
kocytosis. Another theory is that there was no production
at the beginning, and dedifferentiated components
acquired the function of G-CSF production during the
course of tumor development. When leukocytosis
appeared, the tumor had already recurred and metastasis
had developed, and the patient died 2 months after the
surgery. G-CSF has been shown to induce tumor cell pro-
liferation [19-21]. In addition, in a previous report,
tumor-related leukocytosis is linked with poor prognosis
in patients with lung carcinoma. Patients with lung carci-
noma with leukocytosis had a poor outcome compared
with the other patients without leukocytosis [5]. In the
same line, G-CSF may have contributed to the aggressive
behavior of dedifferentiated chondrosarcoma in the cur-
rent case.
It is uncertain whether dedifferentiated chondrosarcoma
consists primarily of two cell types or whether dedifferen-
Roentgenographs show an expansive lesion with punctate calcification in the right pelvic bone (left) Figure 1
Roentgenographs show an expansive lesion with punctate calcification in the right pelvic bone (left). MRI shows a lobulated 
lesion, protuberant to the pelvic cavity, in the pelvic bone with high-intensity on T2-weighted image (right).World Journal of Surgical Oncology 2006, 4:37 http://www.wjso.com/content/4/1/37
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tiation develops secondarily. Molecular genetic study of
one case has shown a substantial number of genetic alter-
ations, as well as severe aneuploidy and loss of heterozy-
gosity in both the components of dedifferentiated
chondrosarcoma [22]. LOH (loss of heterozygosity) in Rb
predominantly occurs in the dedifferentiated components
of dedifferentiated chondrosarcomas [23]. Gene altera-
tions in p53, Rb and FHIT are reported to be responsible
for the "switch" to a high-grade anaplastic sarcoma (ded-
ifferentiated components) from monoclonal origin of
demonstrated dedifferentiated chondrosaroma [24]. It is
also possible that the function of G-CSF production was
acquired as a result of genetic alteration during the course
of tumor development in the current case.
Conclusion
In this report, we present a case of dedifferentiated chon-
drosarcoma with leukocytosis. The leukocytosis seemed
to be associated with an elevated serum G-CSF level,
which may be related to dedifferentiated components in
the current dedifferentiated chondrosarcoma case.
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Dedifferentiated chondrosarcoma; well-differentiated components show conventional chondrosarcoma composed of atypical  chondrocytes with hyaline cartilage matrix (left) and with myxoid matrix (right) (Hematoxylin and Eosin original magnification  × 180). Figure 2
Dedifferentiated chondrosarcoma; well-differentiated components show conventional chondrosarcoma composed of atypical 
chondrocytes with hyaline cartilage matrix (left) and with myxoid matrix (right) (Hematoxylin and Eosin original magnification 
× 180).World Journal of Surgical Oncology 2006, 4:37 http://www.wjso.com/content/4/1/37
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Dedifferentiated chondrosarcoma is characterized by the coexistence of conventional chondrosarcoma (top; left side) and  dedifferentiated components (top; right side) Figure 3
Dedifferentiated chondrosarcoma is characterized by the coexistence of conventional chondrosarcoma (top; left side) and 
dedifferentiated components (top; right side). Dedifferentiated components are composed of atypical spindle cells in a stori-
form pattern, resembling MFH (bottom; left), or osteosarcoma with lace-like osteoid formation (bottom; right). Asterisk (*) 
shows artificial space. (Hematoxylin and Eosin original magnification top; × 50, bottom; × 180).World Journal of Surgical Oncology 2006, 4:37 http://www.wjso.com/content/4/1/37
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